BIIB Jan 2025 120.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 01:50PM EDT
Loading interactive chart…
- Zacks
Amgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
BIIB's pivotal mid to late-stage study evaluating a higher dosing regimen for Spinraza to treat SMA in infants meets the primary and secondary goals.
- Investor's Business Daily
Is Eli Lilly Stock A Buy After Slashing The Price Of Its New Weight-Loss Drug?
Eli Lilly halved the price of a new version of its weight-loss drug, Zepbound. Is Eli Lilly stock a buy right now?
© 2024 Yahoo. All rights reserved.